Protara Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Protara Therapeutics

03/11/2022 14:25

* Protara Therapeutics Inc  TARA.OQ  reported a quarterly
adjusted
loss of 68 cents​​ per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 76 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Protara Therapeutics Inc's reported EPS for the quarter
was a
loss of 68 cents​.
    * The mean earnings estimate of analysts had risen by
about 28.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Protara Therapeutics Inc shares had risen by 0.3% this
quarter and lost 56.0% so far this year.
    * The company reported a quarterly loss of $7.69 million.
    * Wall Street's median 12-month price target for Protara
Therapeutics Inc is $31.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 02:24 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.76          -0.68          Beat
 Jun. 30 2022      -0.94          -0.80          Beat
 Mar. 31 2022      -0.90          -0.96          Missed
 Dec. 31 2021      -0.94          -0.91          Beat